US Stock MarketDetailed Quotes
CALT Calliditas Therapeutics
- 18.653
- -0.848-4.35%
Close Apr 29 16:00 ET
555.68MMarket Cap-11731P/E (TTM)
19.550High17.679Low2.77KVolume19.140Open19.501Pre Close52.32KTurnover0.01%Turnover RatioLossP/E (Static)29.79MShares29.30052wk High18.15P/B404.64MFloat Cap15.25052wk Low--Dividend TTM21.69MShs Float38.000Historical High--Div YieldTTM9.60%Amplitude10.820Historical Low18.902Avg Price1Lot Size
Calliditas Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -39.60%-434.66M | -90.07%22.84M | 49.87%-62.53M | 27.62%-163.03M | 32.55%-311.35M | 230.03M | -275.18%-124.73M | -69.46%-225.23M | -42.66%-191.42M | -49.29%-461.59M |
| Net income from continuing operations | 11.59%-373.06M | 28.52%41.76M | -340.48%-159.57M | 64.18%-75.17M | 19.55%-421.94M | --32.5M | -561.14%-36.23M | -31.65%-209.84M | -38.19%-208.37M | -38.12%-524.46M |
| Depreciation and amortization | 277.34%48.73M | ---- | ---- | ---- | -62.50%12.91M | ---- | ---- | ---- | ---- | 1,119.73%34.43M |
| Other non cash items | -224.04%-19.73M | -579.56%-98.15M | 424.01%58.55M | -151.51%-7.27M | 259.12%15.9M | ---14.44M | 25.38%11.17M | 38.03%14.1M | 1.20%5.07M | 110,800.00%4.43M |
| Change In working capital | -190.18%-79.74M | -115.86%-28.12M | 170.74%60.16M | -134.58%-49.56M | 1,516.45%88.42M | --177.32M | -72.84%-85.05M | -222.01%-21.13M | 47.12%17.29M | -89.89%5.47M |
| -Change in receivables | -98.73%-182.59M | ---- | ---- | ---- | -684.48%-91.88M | ---- | ---- | ---- | ---- | -245.80%-11.71M |
| -Change in inventory | -508.45%-16.78M | ---- | ---- | ---- | -190.62%-2.76M | ---- | ---- | ---- | ---- | ---949K |
| -Change in other current liabilities | -34.65%119.63M | ---- | ---- | ---- | 909.63%183.06M | ---- | ---- | ---- | ---- | -60.63%18.13M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -39.60%-434.66M | -90.07%22.85M | 49.87%-62.53M | 27.62%-163.03M | 32.55%-311.35M | --230.03M | -275.17%-124.73M | -69.46%-225.23M | -42.66%-191.42M | -49.29%-461.59M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -167.17%-13.75M | -60.53%-2.36M | -735.25%-7.42M | 78.86%-5.15M | -1.47M | -276.27%-888K | -1,232.16%-2.65M | 85.90%-24.34M | ||
| Net PPE purchase and sale | -409.08%-12.79M | ---- | ---- | ---- | 61.87%-2.51M | ---- | ---- | ---- | ---- | ---6.59M |
| Net intangibles purchase and sale | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---16.07M |
| Net investment purchase and sale | 63.62%-958K | ---- | ---- | ---- | -56.17%-2.63M | ---- | ---- | ---- | ---- | -33,620.00%-1.69M |
| Net other investing changes | 0.00%1K | 209.65%11.39M | -735.25%-7.42M | ---- | --1K | --3.68M | -276.27%-888K | ---- | -1,232.16%-2.65M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -167.20%-13.75M | -60.57%-2.35M | -735.25%-7.42M | -662.59%-1.06M | 78.87%-5.14M | ---1.47M | -276.27%-888K | 99.25%-139K | -1,232.16%-2.65M | 85.90%-24.34M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -65.34%199.65M | -26.22%208.52M | -12.42%-2.89M | -101.28%-3.02M | 32.36%575.99M | 282.64M | -100.53%-2.57M | 32,996.37%235.87M | 723.82%60.06M | -43.38%435.16M |
| Net issuance payments of debt | -53.07%226.28M | -6.84%235.15M | -12.42%-2.89M | -101.29%-3.02M | 148.59%482.13M | --252.42M | -101.30%-2.57M | 66,748.15%233.94M | -64.16%-1.66M | 4,982.91%193.95M |
| Net common stock issuance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -63.65%324M |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --0 | --95.12M | --31.48M | --0 | --1.93M | --61.71M | --0 |
| Net other financing activities | -2,011.50%-26.63M | ---- | ---- | ---- | 98.48%-1.26M | ---1.26M | ---- | ---- | 99.99%-1K | 53.52%-82.79M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -65.34%199.65M | -26.22%208.52M | -12.42%-2.89M | -101.28%-3.02M | 32.36%575.99M | --282.64M | -100.53%-2.57M | 32,996.37%235.87M | 723.81%60.05M | -43.38%435.16M |
| Net cash flow | ||||||||||
| Beginning cash position | 30.73%1.25B | 6.89%786.88M | 2.29%866.18M | 22.80%1.01B | -4.09%955.51M | --736.16M | 19.38%846.8M | -4.84%825.41M | -4.09%955.51M | 32.22%996.3M |
| Current changes in cash | -195.86%-248.75M | -55.20%229.01M | 43.18%-72.83M | -1,692.40%-167.11M | 611.16%259.49M | --511.2M | -128.28%-128.18M | 106.90%10.49M | 6.93%-134.02M | -117.70%-50.77M |
| Effect of exchange rate changes | -178.05%-26.61M | -2,534.30%-42.16M | -136.84%-6.46M | 80.66%19.69M | 242.00%34.09M | --1.73M | 1,364.44%17.54M | 286.43%10.9M | -73.94%3.92M | 122.65%9.97M |
| End cash Position | -22.04%973.73M | -22.04%973.73M | 6.89%786.88M | 2.29%866.18M | 30.73%1.25B | --1.25B | -36.75%736.16M | 19.38%846.8M | -4.84%825.41M | -4.09%955.51M |
| Free cash flow | -42.56%-447.44M | -95.58%10.06M | 49.87%-62.53M | 27.62%-163.03M | 35.18%-313.87M | --227.52M | -275.17%-124.73M | -69.46%-225.23M | -42.66%-191.42M | -56.62%-484.24M |
| Currency Unit | SEK | SEK | SEK | SEK | SEK | SEK | SEK | SEK | SEK | SEK |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg